StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

GLREBearishEarningsnews
High materiality9/10

Greenlight Re Q2 2026 results show CAT losses, BV decline, and buybacks

Aug 4, 2026, 5:29 PM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

Q2 earnings miss driven by CAT losses and a large investment loss, leading to a net loss and BV decline. The combination of a 100.1% combined ratio and a 3.7% QoQ BV drop suggests near-term price weakness, despite active buybacks. Market perception will hinge on whether reserves, portfolio performance, and reinsurance rates stabilize in the second half, plus any guidance from the earnings call.

AI summary

What happened, with direct paths to the underlying reporting

Greenlight Capital Re reported Q2 2026 results with a net loss of $29.6 million as catastrophe losses weighed on underwriting, driving the combined ratio to 100.1%. Investment losses amplified the earnings miss, while the company continued a capital-return program with sizable share repurchases. Fully diluted book value per share fell 3.7% to $20.61, signaling near-term pressure even as the six-month BV trend modestly improved.

  • Gross premiums written rose 2% to $183.1M; net premiums earned $161.8M.
  • Q2 underwriting produced a $0.2M loss; combined ratio 100.1% due to CAT losses.
  • Total investment loss was $23.8M; net loss $29.6M or $0.89 per share.
  • Share buybacks: $14.2M in Q2; another $3.9M repurchased by Aug 3 at $16.42.
  • Fully diluted BV per share fell 3.7% to $20.61; six-month BV up 0.9%.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.